MUC1 and Familial prostate cancer: In the current study, metformin alone had no significant effect on MUC1 expression; we reasoned that metformin sensitized the therapeutic effect of solamargine in prostate cancer cell growth partly through enhancing the inhibition of MUC1 expression.